In an era characterized by heightened corporate accountability, the biopharmaceutical industry is no exception to the scrutiny surrounding Environmental, Social, and Governance (ESG) practices. In recent years, concerns about the environmental impact of biopharma operations have intensified,
According to the Mayo Clinic , cancer is a term used to describe a wide range of diseases where abnormal cells proliferate uncontrollably, infiltrating and damaging healthy tissues. Cancer can metastasize, spreading throughout the body and affecting more and more organs. Globally, cancer is now the
The COVID-19 pandemic has caused significant disruptions worldwide, altering people’s lifestyles and forcing industries to adapt. Despite the fact that the healthcare crisis has ended, its impact continues to reshape various sectors globally. Businesses have recognized the importance of e
Biotech companies have emerged as key players in driving innovation and transformation in the healthcare sector. Their efforts have led to the development of life-changing treatments and therapies that harness the power of technology to enhance patient care and improve health outcomes. In this
The biopharma industry is rapidly evolving and advancing in 2023. According to the Pharmaceutical Manufacturing Market Size report, its overall growth will continue at a rate of 11.34% from 2021 to 2028 . However, while the industry has long been labeled as recession-proof, organizations must stay
There is no question that cardiovascular diseases (CVDs) are a top priority for scientists and healthcare experts. According to the World Health Organization (WHO), CVDs are the leading cause of death globally , with 17.9 million people dying every year. The most common CVDs include coronary heart
